NH
NHNKY.US Nihon Kohden Corp ADR
- Market cap
- USD 1.53B
- P/E
- 20.2x
- P/B
- 1.35x
- ROE
- 2.2%
- Dividend yield
- 2.13%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is NHNKY.US undervalued?
Graham numberNHNKY.US trades 10.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nihon Kohden Corp ADR fundamental analysis
No fundamental analysis for Nihon Kohden Corp ADR yet.
Nihon Kohden Corp ADR stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nihon Kohden Corp ADR
Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The com…
Full company profileNihon Kohden Corp ADR financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Nihon Kohden Corp ADR annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 166B | 174B | 179B | 185B | 200B | 205B | 207B | 222B | 225B | 249B | 208B |
| Gross Profit | 76.9B | 80.3B | 83.7B | 87.0B | 100B | 107B | 103B | 111B | 117B | 125B | 115B |
| Operating Income | 13.6B | 14.5B | 15.0B | 15.5B | 27.1B | 31.0B | 21.1B | 19.6B | 20.7B | 19.9B | 8.01B |
| EBITDA | 17.2B | 18.0B | 19.2B | 17.7B | 31.6B | 34.5B | 24.9B | 23.4B | 25.9B | 25.7B | 14.6B |
| Net Income | 9.15B | 9.15B | 11.2B | 9.85B | 18.2B | 23.4B | 17.1B | 17.0B | 14.1B | 15.4B | 3.93B |
| EPS | 27 | 27 | 33 | 29 | 54 | 70 | 51 | 51 | 42 | 47 | 12 |
| Balance Sheet | |||||||||||
| Total Assets | 153B | 158B | 170B | 168B | 193B | 210B | 217B | 233B | 258B | 258B | 251B |
| Total Liabilities | 48.9B | 48.5B | 53.6B | 46.0B | 54.0B | 53.8B | 49.1B | 52.2B | 77.0B | 77.0B | 69.6B |
| Shareholders' Equity | 104B | 109B | 116B | 122B | 139B | 156B | 168B | 181B | 180B | 181B | 181B |
| Cash & Short-term Investments | 28.8B | 31.6B | 34.8B | 36.0B | 44.6B | 60.9B | 44.5B | 50.4B | 43.4B | 46.9B | 60.3B |
| Total Debt | 660M | 517M | 435M | 401M | 404M | 359M | 441M | 654M | 26.1B | 25.3B | 23.9B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 11.4B | 10.8B | 9.82B | 9.22B | 13.9B | 25.7B | -2.51B | 15.6B | 15.3B | 22.3B | 38.1B |
| Capital Expenditure | 6.81B | 3.32B | 3.25B | 3.59B | 3.38B | 2.93B | 8.26B | 4.79B | 8.71B | 6.07B | 2.13B |
| Free Cash Flow | 4.55B | 7.53B | 6.57B | 5.63B | 10.6B | 22.8B | -10.8B | 10.8B | 6.58B | 16.3B | 36.0B |
| Ratios | |||||||||||
| ROE | 8.8% | 8.4% | 9.6% | 8.1% | 13.1% | 15.0% | 10.2% | 9.4% | 7.9% | 8.5% | 2.2% |
| ROA | 6.0% | 5.8% | 6.6% | 5.9% | 9.5% | 11.1% | 7.9% | 7.3% | 5.5% | 6.0% | 1.6% |
| Net Profit Margin | 5.5% | 5.3% | 6.3% | 5.3% | 9.1% | 11.4% | 8.3% | 7.7% | 6.3% | 6.2% | 1.9% |
| Debt to Equity | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.15x | 0.14x | 0.13x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Nihon Kohden Corp ADR dividends
- Dividend yield
- 2.13%
- Forward dividend
- 0.20 USD
- Payout ratio
- 36.1%
- Ex-dividend date
- Mar 31, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 5.55B | 17 | 36.1% |
| 2025 | JPY 5.10B | 15 | 36.2% |
| 2024 | JPY 5.97B | 18 | 35.1% |
| 2023 | JPY 5.73B | 17 | 33.5% |
| 2022 | JPY 4.84B | 14 | 20.7% |
| 2021 | JPY 2.98B | 8.86 | 16.3% |
| 2020 | JPY 2.98B | 8.87 | 30.2% |
| 2019 | JPY 2.98B | 8.88 | 26.7% |
| 2018 | JPY 3.00B | 8.91 | 32.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Apr 2, 2015.
Who owns Nihon Kohden Corp ADR
Ownership data of Nihon Kohden Corp ADR is not available yet.
Nihon Kohden Corp ADR company profile
- Company name
- Nihon Kohden Corp ADR
- Ticker
- NHNKY.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 6,116
- Fiscal year end
- March
- Address
- 31-4 Nishiochiai 1-chome, Shinjuku, Japan, 161-8560
- Phone
- 81 3 5996 8000
- Website
- nihonkohden.com
About Nihon Kohden Corp ADR
Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors, including central monitors, bedside monitors, wireless monitors, remote access software and other equipment, clinical information systems, and electrodes and sensors. In addition, it offers defibrillators, automated external defibrillators(AED), ventilators, pacemakers, anesthesia machines, automated chest compression devices, AED pads, batteries, and ablation catheters; hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment and others, consumables, including test reagents, and installation and maintenance services. Further, it is involved in technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
Nihon Kohden Corp ADR management
10- Mr. Hirokazu OginoChairman, President & CEO · born 1970
- Tomonari MaedaOperating Officer, Deputy GM of Corporate Administration Operations & SM of Finance Department
- Mr. Eiichi TanakaExecutive VP, COO & GM of Domestic Business Headquarters and Corporate Director · born 1962
- Hirohiko IkeyaOperating Officer, CTO & GM of Technology Development Operations
- Mr. Kazuhiro KatoSr. Op. Off., CAO & GM of Corp. Adm. Ope. and Chief Com. Off. & Corporate Director · born 1965
- Mr. Yasuhiro YoshitakeExecutive Operating Officer, CSO & Corporate Director · born 1966
- Kaoru ImajoOperating Officer, CIO, GM of Neurology Bus. Divi. & CEO of Ad-Tech Medical Instrument Co.
- Yoshiyuki FujitaOp. Officer, Chief Quality & Regulatory Officer & GM of Corporate Quality Mgmt. Op.
- Naoto NishiiExecutive Officer & Head of Business Strategy Headquarters
- Keichiro YoshizawaExecutive Officer & Head of North American Business Headquarters